E-LIB Suche - Ergebnisse für: Aikin, Kathryn J

1

Physician interpretation of information about prescription ..:

Aikin, Kathryn J. ; O'Donoghue, Amie C. ; Miles, Stephanie..
Research in Social and Administrative Pharmacy. 20 (2024) 4 - p. 419-431 , 2024

Link: https://doi.org/10.1016/..

2

Disease Awareness and Prescription Drug Communications on T..:

Betts, Kevin R. ; Aikin, Kathryn J. ; Miles, Stephanie.
Health Communication. , 2024

Link: https://doi.org/10.1080/..

3

Complexity of Data Displays in Prescription Drug Advertisem..:

Thompson, Jessica ; Lynch, Molly ; Sullivan, Helen W....
Therapeutic Innovation & Regulatory Science. 57 (2023) 4 - p. 712-716 , 2023

Link: https://doi.org/10.1007/..

4

Implied Claims in Drug Advertising: A Review of Recent Lite..:

Aikin, Kathryn J. ; Boudewyns, Vanessa ; Betts, Kevin R....
Health Communication. 39 (2023) 4 - p. 652-665 , 2023

Link: https://doi.org/10.1080/..

5

Physicians' use of and preferences for FDA-approved prescri..:

Sullivan, Helen W. ; Squire, Claudia ; Aikin, Kathryn J....
Research in Social and Administrative Pharmacy. 18 (2022) 6 - p. 3027-3037 , 2022

Link: https://doi.org/10.1016/..

6

Attention to risk information in direct‐to‐consumer prescri..:

Aikin, Kathryn J. ; Sullivan, Helen W. ; Caporaso, Andrew...
Pharmacoepidemiology and Drug Safety. 32 (2022) 3 - p. 312-320 , 2022

Link: https://doi.org/10.1002/..

7

Physician Perceptions of the FDA's Breakthrough Therapy Des..:

Paquin, Ryan S ; Boudewyns, Vanessa ; O'Donoghue, Amie C.
The Oncologist. 27 (2022) 1 - p. e85-e88 , 2022

Link: https://doi.org/10.1093/..

8

Influence of data disclosures on physician decisions about ..:

Chansky, Melanie C. ; Price, Simani M. ; Aikin, Kathryn J..
BMC Primary Care. 23 (2022) 1 - p. , 2022

Link: https://doi.org/10.1186/..

9

Physician Interpretation of Data of Uncertain Clinical Util..:

Boudewyns, Vanessa ; O'Donoghue, Amie C. ; Paquin, Ryan S....
The Oncologist. 26 (2021) 12 - p. 1071-1078 , 2021

Link: https://doi.org/10.1002/..

10

What influences healthcare providers' prescribing decisions..:

Price, Simani M. ; O'Donoghue, Amie C. ; Rizzo, Lou..
Research in Social and Administrative Pharmacy. 17 (2021) 10 - p. 1770-1779 , 2021

Link: https://doi.org/10.1016/..

11

Utilization of adequate provision in prescription drug broa..:

Betts, Kevin R. ; Aikin, Kathryn J. ; Burke, Panne..
Health Marketing Quarterly. 39 (2021) 1 - p. 4-22 , 2021

Link: https://doi.org/10.1080/..

12

Development and validation of prescription drug risk, effic..:

Kelly, Bridget J. ; Rupert, Douglas J. ; Aikin, Kathryn J....
Research in Social and Administrative Pharmacy. 17 (2021) 5 - p. 942-955 , 2021

Link: https://doi.org/10.1016/..

13

Consumers' experience with and attitudes toward direct-to-c..:

Aikin, Kathryn J. ; Sullivan, Helen W. ; Berktold, Jennifer..
Health Marketing Quarterly. 38 (2021) 1 - p. 1-11 , 2021

Link: https://doi.org/10.1080/..

14

The FDA's Diverse and Dynamic Activities in the Social and ..:

Lee, Christine ; McLean, Melanie J. ; Huang, Caroline J....
Journal of Primary Care & Community Health. 12 (2021) - p. 215013272110047 , 2021

Link: https://doi.org/10.1177/..

15

Consumer responses to framing statements preceding the majo..:

Aikin, Kathryn J. ; Betts, Kevin R. ; Boudewyns, Vanessa..
Research in Social and Administrative Pharmacy. 16 (2020) 9 - p. 1237-1247 , 2020

Link: https://doi.org/10.1016/..